REGENXBIO Inc Sustainability Reports
REGENXBIO Inc. is a clinical-stage biotechnology company focused on the development, commercialization, and licensing of gene therapies using its proprietary adeno-associated virus delivery platform.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 549300EOES47LATSET33
FIGI: BBG007Z9V5C7
3 reports from 2017 to 2023